Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Dexketoprofen trometamol: An NSAID with improved safety and efficacy

Jan. 8, 1997

Hoechst Japan describes immunosuppressive peptides

Jan. 8, 1997

ImmuLogic files U.S. IND application for MS therapeutic

Jan. 7, 1997

First launch for Sumitomo antidepressant

Jan. 7, 1997

Novel analgesic/antiinflammatory agents from Sanwa Shoyaku

Jan. 7, 1997

Cephalon files first NDA submission

Jan. 3, 1997

Cambridge NeuroScience/Gladstone Institute AD collaboration

Jan. 3, 1997

German investigators present potent dopamine D1 antagonist

Jan. 3, 1997

Nippon Zoki claims aFGF fragments for CNS indications

Jan. 3, 1997

Debate centers on the safety of coated aspirin

Jan. 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...